Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations

Bookmark and Share
Published: 10 Jul 2019
Views: 233
Rating:
Save
Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA

Prof Funda Meric-Bernstam speaks to ecancer at the WIN 2019 Symposium in Paris about the use of genomic testing to direct genomically-informed patient care.

She states that the main challenge of this type of testing is the interpretation of results, the increasing appearance of uncommon mutations and access to the different therapeutic options available.

To overcome these challenges, Prof Meric-Bernstam explains that they are putting a platform in place to support oncologists in interpreting these results.